Paper39928343
Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers.
VandeVrede L and 24 others. JAMA Neurol, 2025. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers. Papers, record 39928343. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39928343
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 AG062422 | NIA NIH HHS | United States | P30AG062422 | PubMed | NIH RePORTER |
| R01 AG059794 | NIA NIH HHS | United States | R01AG059794 | PubMed | NIH RePORTER |
| R01 AG062758 | NIA NIH HHS | United States | R01AG062758 | PubMed and NIH | NIH RePORTER |
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28259709 | Consensus classification of posterior cortical atrophy. | Alzheimers Dement | 2017 | https://conductscience.org/library/papers/28259709 | PubMed |
| 2 | 21810890 | Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. | Brain | 2011 | https://conductscience.org/library/papers/21810890 | PubMed |
| 3 | 32722745 | Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. | JAMA | 2020 | https://conductscience.org/library/papers/32722745 | PubMed |
| 4 | 23359374 | Criteria for the diagnosis of corticobasal degeneration. | Neurology | 2013 | https://conductscience.org/library/papers/23359374 | PubMed |
| 5 | 36449413 | Lecanemab in Early Alzheimer's Disease. | N Engl J Med | 2023 | https://conductscience.org/library/papers/36449413 | PubMed |
| 6 | 16914880 | Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. | J Alzheimers Dis | 2006 | https://conductscience.org/library/papers/16914880 | PubMed |
| 7 | 37010841 | Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome. | JAMA Neurol | 2023 | https://conductscience.org/library/papers/37010841 | PubMed |
| 8 | 37985230 | Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals. | Alzheimers Dement | 2024 | https://conductscience.org/library/papers/37985230 | PubMed |
| 9 | 38578117 | Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy. | Ann Neurol | 2024 | https://conductscience.org/library/papers/38578117 | PubMed |
| 10 | 29053860 | Clinicopathological correlations in behavioural variant frontotemporal dementia. | Brain | 2017 | https://conductscience.org/library/papers/29053860 | PubMed |
| 11 | 22101365 | National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. | Acta Neuropathol | 2012 | https://conductscience.org/library/papers/22101365 | PubMed |
| 12 | 36575455 | Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels. | Mol Neurodegener | 2022 | https://conductscience.org/library/papers/36575455 | PubMed |
| 13 | 38023620 | Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations. | Alzheimers Dement (N Y) | 2023 | https://conductscience.org/library/papers/38023620 | PubMed |
| 14 | 28592453 | Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. | Neurology | 2017 | https://conductscience.org/library/papers/28592453 | PubMed |
| 15 | 28467028 | Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. | Mov Disord | 2017 | https://conductscience.org/library/papers/28467028 | PubMed |
| 16 | 38159140 | Optimal blood tau species for the detection of Alzheimer's disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study. | Acta Neuropathol | 2023 | https://conductscience.org/library/papers/38159140 | PubMed |
| 17 | 31914218 | Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium. | Alzheimers Dement | 2020 | https://conductscience.org/library/papers/31914218 | PubMed |
| 18 | 33773595 | Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment. | Alzheimers Res Ther | 2021 | https://conductscience.org/library/papers/33773595 | PubMed |
| 19 | 37202517 | Blood biomarkers for Alzheimer's disease in clinical practice and trials. | Nat Aging | 2023 | https://conductscience.org/library/papers/37202517 | PubMed |
| 20 | 25282381 | Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research. | Alzheimers Dement | 2015 | https://conductscience.org/library/papers/25282381 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42926663 | MTHFR*677C>T produces distinct prodromal disease signatures in a mouse model of late-onset Alzheimer's disease. | Res Sq | 2026 | https://conductscience.org/library/papers/42926663 | PubMed |
| 42897209 | Phosphorylated tau 217 in young adults with Down syndrome and Down syndrome regression disorder. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/42897209 | PubMed |
| 42851246 | Associations between plasma biomarker levels and quantitative postmortem neuropathologic measures in Alzheimer's disease and related dementias. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42851246 | PubMed |
| 42851168 | Plasma eMTBR-tau243 as a disease biomarker across Alzheimer's disease clinical phenotypes. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42851168 | PubMed |
| 42690439 | Changes in five cerebrospinal fluid and three plasma Alzheimer's disease biomarkers across increasing brain amyloid-beta and tau pathology burden. | Acta Neuropathol | 2026 | https://conductscience.org/library/papers/42690439 | PubMed |
| 42608726 | Biomarker-based assessment of cerebral small vessel disease progression after ischemic stroke - a prospective cohort study (MA-BIO). | Neurol Res Pract | 2026 | https://conductscience.org/library/papers/42608726 | PubMed |
| 42584831 | Cognitive components derived from traditional neuropsychological tests and their associations with plasma p-tau217 and p-tau181 in mild cognitive impairment: a multisite analysis. | Geroscience | 2026 | https://conductscience.org/library/papers/42584831 | PubMed |
| 42557932 | Lecanemab use in Chinese patients with Alzheimer's disease: a 12-month multicenter real-world study. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42557932 | PubMed |
| 42535261 | Exploring longitudinal relationships among Alzheimer's disease biomarkers. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42535261 | PubMed |
| 42440317 | Plasma Phosphorylated Tau 217 in Participants at Risk for Chronic Traumatic Encephalopathy. | JAMA Netw Open | 2026 | https://conductscience.org/library/papers/42440317 | PubMed |
| 42405663 | Diagnostic Value of Neurofilament Light Chain and Glial Fibrillary Acidic Protein in Differentiating Primary From Serious Secondary Headache. | Eur J Neurol | 2026 | https://conductscience.org/library/papers/42405663 | PubMed |
| 42402014 | Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals Programme. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42402014 | PubMed |
| 42335710 | A multiverse analysis of the logical memory test and plasma biomarkers of Alzheimer's disease. | Cortex | 2026 | https://conductscience.org/library/papers/42335710 | PubMed |
| 42324487 | Emerging directions in tauopathy research. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42324487 | PubMed |
| 42323462 | Plasma p-Tau217 and Aβ42/Aβ40 mediate the association between minimal depressive symptoms and cognitive impairment. | J Neurol | 2026 | https://conductscience.org/library/papers/42323462 | PubMed |
| 42245135 | Cognitive decline and reduced bone mineral density under the bone-brain axis: mechanistic insights and imaging evaluation strategies. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42245135 | PubMed |
| 42182262 | Digital Atlases to Unlock the Potential of Brain Biorepository Tissues for Interdisciplinary Research. | bioRxiv | 2026 | https://conductscience.org/library/papers/42182262 | PubMed |
| 42028213 | From clinical judgment to biology: a clinician's opinion on the use of blood-based biomarkers in Alzheimer's disease. | Front Neurol | 2026 | https://conductscience.org/library/papers/42028213 | PubMed |
| 42009653 | Diagnostic performance of plasma p-tau217 levels measured with different assays for Alzheimer's disease. | Transl Psychiatry | 2026 | https://conductscience.org/library/papers/42009653 | PubMed |
| 41973869 | Feasibility of Internet-Based Mind-Body Training for Adults With Subjective Cognitive Decline: Protocol for a Randomized Controlled Trial. | JMIR Res Protoc | 2026 | https://conductscience.org/library/papers/41973869 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GFAP | 2670 | PubTator's text mining | https://conductscience.org/library/genes/2670 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| NEFL | 4747 | PubTator's text mining | https://conductscience.org/library/genes/4747 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39928343
GET https://conductscience.org/api/papers/v1/39928343/authors?page=2